R K Pharma
Signal active
Organization
Contact Information
Overview
RK Pharma develops and contributes to the health care industry with pharmaceutical ingredients and generic products. Their products include diclofenac potassium tablets, mycophenolic acid DR tablets, mycophenolic acid DR tablets, mitomycin injection vials, and more.
About
Industries
Health Care, Pharmaceutical, Manufacturing
Founded
2018
Employees
1001-5000
Headquarters locations
New York, United States, North America
Social
N/A
Profile Resume
R K Pharma headquartered in New York, United States, North America, operates in the Health Care, Pharmaceutical, Manufacturing sector. The company focuses on Health Care and has secured $2.4B in funding across 12 round(s). With a team of 1001-5000 employees, R K Pharma is actively contributing to advancements in Health Care. Their latest funding round, Private Equity Round - R K Pharma, raised $200.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
1
Investors
1
Lead Investors
0
Total Funding Amount
$200.0M
Details
1
R K Pharma has raised a total of $200.0M in funding over 1 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2023 | Private Equity | 200.0M |
Investors
R K Pharma is funded by 2 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| R K Pharma | - | FUNDING ROUND - R K Pharma | 200.0M |
| PAG | - | FUNDING ROUND - PAG | 200.0M |
Recent Activity
There is no recent news or activity for this profile.